Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Conroy

Showing results (451-460 of 481) with videos related to

Pageof 49
Sort By:
The Journal of Molecular Diagnostics : JMD|August 24, 2018
OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric MalignanciesMatthew C Hiemenz, Dejerianne G Ostrow, Tracy M Busse, et al.
Journal of Medical Genetics|October 11, 2017
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from MalaysiaWei Xiong Wen, Jamie Allen, Kah Nyin Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancerCarl D Morrison, Pengyuan Liu, Anna Woloszynska-Read, et al.
BMC Medical Informatics and Decision Making|January 20, 2019
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencingGrace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos, et al.
Oncoimmunology|September 14, 2020
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patientsTian Zhang, Sarabjot Pabla, Felicia L Lenzo, et al.
Journal for Immunotherapy of Cancer|May 11, 2018
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burdenCarl Morrison, Sarabjot Pabla, Jeffrey M Conroy, et al.
Journal for Immunotherapy of Cancer|January 26, 2019
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitorsJeffrey M Conroy, Sarabjot Pabla, Mary K Nesline, et al.
Journal for Immunotherapy of Cancer|February 3, 2019
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patientsSarabjot Pabla, Jeffrey M Conroy, Mary K Nesline, et al.
Molecular Genetics & Genomic Medicine|May 9, 2019
The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association ConsortiumTomotaka Ugai, Roger L Milne, Hidemi Ito, et al.
Nature Human Behaviour|December 25, 2019
Author Correction: A consensus-based transparency checklistBalazs Aczel, Barnabas Szaszi, Alexandra Sarafoglou, et al.
Pageof 49

Showing results (451-460 of 481) with videos related to

Sort By:
Pageof 49
The Journal of Molecular Diagnostics : JMD|August 24, 2018
OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric MalignanciesMatthew C Hiemenz, Dejerianne G Ostrow, Tracy M Busse, et al.
Journal of Medical Genetics|October 11, 2017
Inherited mutations in <i>BRCA1</i> and <i>BRCA2</i> in an unselected multiethnic cohort of Asian patients with breast cancer and healthy controls from MalaysiaWei Xiong Wen, Jamie Allen, Kah Nyin Lai, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
Whole-genome sequencing identifies genomic heterogeneity at a nucleotide and chromosomal level in bladder cancerCarl D Morrison, Pengyuan Liu, Anna Woloszynska-Read, et al.
BMC Medical Informatics and Decision Making|January 20, 2019
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencingGrace K Dy, Mary K Nesline, Antonios Papanicolau-Sengos, et al.
Oncoimmunology|September 14, 2020
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patientsTian Zhang, Sarabjot Pabla, Felicia L Lenzo, et al.
Journal for Immunotherapy of Cancer|May 11, 2018
Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burdenCarl Morrison, Sarabjot Pabla, Jeffrey M Conroy, et al.
Journal for Immunotherapy of Cancer|January 26, 2019
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitorsJeffrey M Conroy, Sarabjot Pabla, Mary K Nesline, et al.
Journal for Immunotherapy of Cancer|February 3, 2019
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patientsSarabjot Pabla, Jeffrey M Conroy, Mary K Nesline, et al.
Molecular Genetics & Genomic Medicine|May 9, 2019
The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association ConsortiumTomotaka Ugai, Roger L Milne, Hidemi Ito, et al.
Nature Human Behaviour|December 25, 2019
Author Correction: A consensus-based transparency checklistBalazs Aczel, Barnabas Szaszi, Alexandra Sarafoglou, et al.
Pageof 49